Error: Could not add to watchlist. X

Galapagos NV

+ Watchlist
GLPG:BB
EN Brussels
EUR
Volume
0
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (EUR) (TTM)
-1.82
Market Cap (EUR)
-
Shares Outstanding (m)
45.837
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Galapagos NV operates as a clinical stage biotech company. The Company develops and commercializes novel medicines and progressing pipelines in biotech with phase 2 programs, phase 1 programs, pre-clinical, and discovery programs.
ADDRESS
Generaal De Wittelaan L11 A3
Industriepark Mechelen Noord
Mechelen, 2800
Belgium
PHONE
32-15-34-2900
Show More